The Detroit Regional Chamber’s annual Mackinac Policy Conference.
Chris Holman speaks with Dr. Norman Beauchamp, executive vice president of health sciences. the lead creator of the Henry Ford Health and MSU Health Sciences partnership from Media Row, at the Grand Hotel, while at the 2023 Mackinac Policy Conference.
Watch Norman and Chris discuss MSU Health Sciences and their recent activity at the #MPC23 click play on the YouTube video below.
Shared below is the earlier release at the initial launch shortly before the Mackinac Policy Conference.
HFH+MSU HS:
Example of an opportunity that might not have happened without the partnership: https://msutoday.msu.edu/news/2023/msu-medical-student-selected-to-work-with-detroit-lions
GR Innovation Park story that came out:
Collaboration between MSU researcher, Helen DeVos doctor, lands $4M NIH grant to study rare children’s disease
EAST LANSING [BN1], Mich. – A Michigan State University College of Human Medicine professor and a Helen DeVos Children’s Hospital physician have joined forces [ZL2] to study a rare genetic disease that, until recently, was completely unknown. Their combined efforts have resulted in a novel disorder diagnosis, a therapeutic treatment and – now – a $4M National Institutes of Health grant to further their research and understanding.
The collaboration between the two scientists – André Bachmann, an MSU professor of pediatrics, and Caleb Bupp, a medical geneticist at the Corewell Health-affiliated children’s hospital in Grand Rapids, Michigan – grew out of the case of a 3-year-old girl whose symptoms included complete hair loss, an enlarged head, low muscle tone, and developmental delays.
Bupp recalled that he and other physicians couldn’t figure out what condition she had, although a genetic test revealed a mutation in a gene called ornithine decarboxylase 1, or ODC1.
